Priorities and Goals
Positioning The Wistar Institute as a world leader in a new era of scientific discovery requires investments in state-of-the-art facilities and in our faculty—both of which are priorities for the Building Wistar, Changing the World Campaign.
Facilities: $25 million
Soon a new Wistar research tower will rise from our existing footprint, a contemporary and dramatically silhouetted space that will herald an engine of discovery and an international leader in biomedical research.
Designed specifically to meet the needs of team science today and in the future, the tower will feature larger, more flexible laboratory space that can be easily reconfigured to meet changing research needs, and open-plan laboratories and common areas for scientists and staff to encourage collaboration and interaction.
Increased investment in new DNA sequencing and array technologies, imaging technologies, chemistry facilities and mass spectrometry will provide scientists with state of the art technologies and high-powered computational tools needed to advance their research.
In addition, a new public entrance on Spruce Street, a skylit atrium and 196-seat auditorium will enhance Wistar’s identity and enable enhanced public outreach.
Wistar’s brand of team science naturally spurs discovery as researchers cross-pollinate ideas and brainstorm at will.
The Building Wistar, Changing the World Campaign will forever break down barriers to the free flow of creative ideas, building optimal environments that will inject greater spontaneity, foster more connectivity and spark livelier discussions inside and outside the laboratory.
Faculty: $10 million
Institutional growth is about more than space and size. It is about our most precious resources, the scientists of Wistar. They are the talent behind the discoveries that improve health and medical care around the world.
Our faculty’s achievements are astounding considering Wistar’s relatively small size. In just the past decade, we have pioneered dozens of breakthroughs including:
Developing techniques that use monoclonal antibodies to help physicians monitor pancreatic cancer and eradicate remaining malignancy following brain cancer surgery.
Determining the structure of telomerase, an enzyme that facilitates the spread of 90 percent of cancers.
Uncovering the gene p21’s role in tissue regeneration.
Creating a promising HIV vaccine, which is already on the path to clinical trials.
By increasing the number of laboratories from 30 to 40, the Building Wistar, Changing the World Campaign will bring Wistar up to size, matching most peers and helping us attain a critical mass of faculty positions by 2014. Our carefully planned recruitment will replace retiring researchers and fill new positions. Most important, this approach will diversify the Wistar faculty, augmenting the strengths of our current senior researchers with new and complementary expertise in emerging areas of science that represent today’s frontiers of discovery.